Buprenorphine is on the market as being a monoproduct or in a very blended formulation with naloxone, an opioid antagonist, used to reduce diversion simply because buprenorphine put together with naloxone causes extreme withdrawal symptoms when injected. However, naloxone is not orally active, so withdrawal symptoms do not come about when used subl